Become a logicalchat Member

Latest Post

How Can You Tell What Professional Stock Analysts Recommend?

Stock analysts are experts who provide valuable insights into financial markets, helping investors make informed decisions. Their recommendations, based on thorough research and data...

Your story starts here. Sign up and let's connect in ways that truly matter!

HomeUncategorizedToday's Top Performers: CrowdStrike, HPE, Stitch, Mind Medicine and More Make Big...

Today’s Top Performers: CrowdStrike, HPE, Stitch, Mind Medicine and More Make Big Moves.

Today, Stock futures were trading higher in the premarket hours , building on the bullish close in the last session ahead of significant economic data anticipated later

Top stock gainers


CrowdStrike (NASDAQ:CRWD) shares increased roughly 7% following a stronger than expected 1Q25 earnings performance, with net new ARR growth of 22% and overall ARR growth of 33% Y/Y. The business sees Q2 EPS to range from $0.98 to $0.99, above the consensus of $0.91, and sales to range from $958M to $961M, beating the analysts’ estimate of $954M.


Shares of Hewlett Packard Enterprise (NYSE:HPE) soared over 15% after beating the consensus mark in FQ2 earnings and presenting an enthusiastic outlook. For FQ3, the firm expects to earn between $0.43 and $0.48 per share vs. the consensus of $0.46, with revenue between $7.4B and $7.8B, compared to the consensus of $7.45B. The business also raised its full-year estimate and now sees revenue growth between 1% and 3% on a constant currency basis, compared to a prior view of flat to 2% growth. Adjusted EPS is predicted to decrease between $1.85 and $1.95, with the midpoint above the consensus of $1.88.


Despite sales down about 16% Y/Y and active clients down around 20%, Stitch Fix (NASDAQ:SFIX) gained 18% after outperforming expectations in the FQ3 result. The company also forecasts revenue for FQ4 and FY2024 beyond market projections. Stitch Fix (SFIX) estimates FQ4 net revenue to be between $312M and $322M vs. the consensus of $306.57M, and FY2024 revenue between $1.33B and $1.34B vs. the consensus of $1.31B.

Top stock losses

Mind Medicine (NASDAQ:MNMD) shares dropped more than 20% after the U.S. Food and chemical Administration voted against a therapy based on the mind-altering chemical MDMA for patients with post-traumatic stress disorder, delivering a blow to the burgeoning field of psychedelic medicines. The panel voted 10-to-1, concluding that the benefits did not exceed the hazards and that the current data did not indicate its effectiveness.

Premarket

Gainers

WalkMe (NASDAQ:WKME) stock rose over 40% after the German enterprise software major SAP stated Wednesday it has agreed to acquire the parent of the travel and expenditure management platform Concur, in an all-cash deal valued at around $1.5 billion.

Hewlett Packard Enterprise (NYSE:HPE) jumped 15% after the software consultant reported solid quarterly earnings and gave an optimistic outlook on the strength of artificial intelligence demand.

CrowdStrike (NASDAQ:CRWD) surged 11% after the cybersecurity business boosted its annual expectations following stronger-than-expected quarterly profits.

Intel (NASDAQ:INTC) stock increased 0.9% after buyout firm Apollo Global Management (NYSE:APO) agreed to purchase a 49% equity interest for $11 billion in a joint venture relating to the chipmaker’s Ireland manufacturing business.

Deere & Company (NYSE:DE) stock climbed 0.4% after the agriculture machinery giant said it would slash an undefined number of production and salaried jobs to save expenses as it grapples with a decline in farm equipment demand.

Losers

Dollar Tree (NASDAQ:DLTR) stock dipped 1.9% amid a report that the discount retailer wants to investigate options that include a potential sale or spin-off of Family Dollar.

Hibbett Sports (NASDAQ:HIBB) stock dipped 1.5% after the sporting good retailer revealed that quarterly sales came in below projections.

Spirit AeroSystems (NYSE:SPR) stock dipped 1.1% after the aerospace supplier stated Mark Suchinski is stepping down as Chief Financial Officer.

Stock in Focus

Must read book about investing – check here

After reporting 8% Y/Y subscription revenue growth in 4Q24, DocuSign (NASDAQ:DOCU) shares rose 10%. Electronic signature business predicts 1Q25 revenue of $704M to $708M, above analysts’ $699.1M forecast. DocuSign expects sales of $2.91B to $2.92B this year, with consensus of $2.91B. Customer adoption of Contract Lifecycle Management and eSignature in StateRAMP-authorized environments was also emphasized by the organization.

MongoDB (NASDAQ:MDB) shares fell 8% after exceeding Q4 profit and sales forecasts owing to its dovish FY2025 outlook. MongoDB expects revenues of $436M to $440M in Q1, below the average expectation of $449.08M. Below the estimate of $0.61, non-GAAP EPS is expected to be $0.34–$0.39. The business estimates FY2024 sales between $1.9B and $1.93B, below the average of $2.03B. Unlike the consensus of $3.22, non-GAAP EPS is expected to be $2.27 to $2.49.

Marvell Technology (NASDAQ:MRVL) shares fell over 7% after solid Q4 earnings due to a dismal Q1 guidance. The business predicts Q1 sales of $1.15B, plus or less 5%, behind analysts’ $1.36B. Marvell predicts adjusted gross margins of 62% to 63% and adjusted earnings of $0.18 to $0.28 per share, significantly below the average forecast of $0.40. Marvell announced $3B in stock buybacks.

Despite a 5.7% Y/Y rise, Costco Wholesale’s NASDAQ:COST shares plummeted roughly 4% as its FQ2 earnings reports fell short of the top-line estimate. Comparable sales increased by 5.6% during the quarter, above the 5.1% estimate.

MongoDB (NASDAQ:MDB) shares fell 8% after exceeding Q4 profit and sales forecasts owing to its dovish FY2025 outlook. MongoDB expects revenues of $436M to $440M in Q1, below the average expectation of $449.08M. Below the estimate of $0.61, non-GAAP EPS is expected to be $0.34–$0.39. The business estimates FY2024 sales between $1.9B and $1.93B, below the average of $2.03B. Unlike the consensus of $3.22, non-GAAP EPS is expected to be $2.27 to $2.49.

Marvell Technology (NASDAQ:MRVL) shares fell over 7% after solid Q4 earnings due to a dismal Q1 guidance. The business predicts Q1 sales of $1.15B, plus or less 5%, behind analysts’ $1.36B. Marvell predicts adjusted gross margins of 62% to 63% and adjusted earnings of $0.18 to $0.28 per share, significantly below the average forecast of $0.40. Marvell announced $3B in stock buybacks.

Despite a 5.7% Y/Y rise, Costco Wholesale’s NASDAQ:COST shares plummeted roughly 4% as its FQ2 earnings reports fell short of the top-line estimate. Comparable sales increased by 5.6% during the quarter, above the 5.1% estimate.

Related Post